PULSE THERAPEUTICS, INC.

Profile

Company Names

PULSE THERAPEUTICS, INC.

Addresses

911 WASHINGTON AVENUE, SUITE 730, ST. LOUIS, MO 63101

611 OLIVE STREET, SUITE 1260, ST. LOUIS, MO 63101

4041 FOREST PARK AVENUE, ST. LOUIS, MO 63108

Phone Numbers

314-787-7475
314-974-1909

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$11,380,708.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2016-01-12 
$5,615,708.00 
$13,754,074.00 
$8,138,366.00 
Equity 
3
2013-12-23 
$1,025,000.00 
$1,500,000.00 
$475,000.00 
Equity 
2
2011-12-15 
$3,090,000.00 
$3,090,000.00 
$0.00 
Equity 
1
2011-04-06 
$1,650,000.00 
$2,000,000.00 
$350,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
AMY 
L. 
BOYET 
EXECUTIVE OFFICER
PULSE THERAPEUTICS, INC.
DANIEL 
J. 
BRODERICK 
DIRECTOR
PULSE THERAPEUTICS, INC.
FRANCIS 
M. 
CREIGHTON 
EXECUTIVE OFFICER, DIRECTOR
PULSE THERAPEUTICS, INC.
PETER 
S. 
FINLEY 
EXECUTIVE OFFICER
PULSE THERAPEUTICS, INC.   |  OBSERVABLE NETWORKS, INC.
ERIC 
A. 
GULVE 
DIRECTOR
CARDIALEN, INC.   |  PULSE THERAPEUTICS, INC.
THOMAS 
 
HILLMAN 
DIRECTOR
AFCV HOLDINGS LLC   |  LEWIS + CLARK VENTURES I PARALLEL FUND, LP   |  PULSE THERAPEUTICS, INC.   |  EUPHRATES VASCULAR, INC.   |  IT HOLDING COMPANY, LLC
THOMAS 
J. 
HILLMAN 
DIRECTOR
PULSE THERAPEUTICS, INC.   |  CHP GA FUND III, LLC   |  COMMUNITY HOUSING PARTNERS, LLC   |  CHP MO FUND II, LLC   |  CHP GA FUND I, LLC   |  CHP GA FUND II, LLC   |  LEWIS + CLARK VENTURES I, LP   |  IRONROCK REAL ESTATE INVESTMENT FUND, LP   |  LEWIS + CLARK PLANT SCIENCES FUND I, LP   |  LEWIS + CLARK AGRIFOOD FUND II, L.P.   |  LEWIS + CLARK VENTURES II, L.P.   |  LEWIS + CLARK AGRIFOOD FUND III, LP
BEVIL 
J. 
HOGG 
DIRECTOR
ENDOSTIM, INC.   |  PULSE THERAPEUTICS, INC.   |  SPECIALISTS ON CALL INC   |  ELIRA, INC.
ERIC 
 
MOESSINGER 
DIRECTOR
EMULATE, INC.   |  PULSE THERAPEUTICS, INC.   |  MUSE BIOTECHNOLOGY, INC.   |  SQZ BIOTECHNOLOGIES CO   |  SEROTINY, INC.   |  EUPHRATES VASCULAR, INC.   |  AMPHIVENA THERAPEUTICS, INC.   |  ICOSAVAX, INC.   |  VISBY MEDICAL, INC.   |  PARTILLION BIOSCIENCE CORP   |  DRAGON VASCULAR, INC.
SEAN 
 
MORRIS 
EXECUTIVE OFFICER, DIRECTOR
VENITI, INC.   |  THELOCKER, INC.   |  PULSE THERAPEUTICS, INC.   |  EUPHRATES VASCULAR, INC.   |  NAA LLC   |  ARTIO MEDICAL, INC.   |  AMPLIFI INVESTORS, LLC   |  AMPLIFI VASCULAR, INC.   |  CORVION INC.   |  CULTIVATION CAPITAL LIFE SCIENCES FUND IV, LP
ROGERS 
 
RITTER 
EXECUTIVE OFFICER
PULSE THERAPEUTICS, INC.
PEGGY 
 
STOHR 
EXECUTIVE OFFICER
VERTO MEDICAL SOLUTIONS, LLC   |  ENDOSTIM, INC.   |  PULSE THERAPEUTICS, INC.
JAMES 
C. 
WACHTMAN 
EXECUTIVE OFFICER
PULSE THERAPEUTICS, INC.   |  IOR HOLDINGS, INC.
STEPHEN 
A. 
WEXLER 
DIRECTOR
PULSE THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-01-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-01-12 
2014-02-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-23 
2011-12-30
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2011-12-15 
2011-08-01
D/A
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2011-04-06 
2011-04-21
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2011-04-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#